1. Nat Genet. 2013 Jun;45(6):670-5. doi: 10.1038/ng.2616. Epub 2013 Apr 21.

Dense genotyping of immune-related disease regions identifies nine new risk loci 
for primary sclerosing cholangitis.

Liu JZ(1), Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, 
Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield 
GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, 
Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen MM, Herms S, Winkelmann J, 
Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, Sterneck M, Teufel A, Mason AL, 
Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich SS, 
Thompson WK, Schork AJ, Næss S, Thomsen I, Mayr G, König IR, Hveem K, Cleynen I, 
Gutierrez-Achury J, Ricaño-Ponce I, van Heel D, Björnsson E, Sandford RN, Durie 
PR, Melum E, Vatn MH, Silverberg MS, Duerr RH, Padyukov L, Brand S, Sans M, 
Annese V, Achkar JP, Boberg KM, Marschall HU, Chazouillères O, Bowlus CL, 
Wijmenga C, Schrumpf E, Vermeire S, Albrecht M; UK-PSCSC Consortium; Rioux JD, 
Alexander G, Bergquist A, Cho J, Schreiber S, Manns MP, Färkkilä M, Dale AM, 
Chapman RW, Lazaridis KN; International PSC Study Group; Franke A, Anderson CA, 
Karlsen TH; International IBD Genetics Consortium.

Collaborators: Abraham C, Ahmad T, Amininejad L, Ananthakrish AN, Andersen V, 
Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brant SR, 
Büning C, Cichon S, Cohain A, Daly MJ, DeJong D, Devaney KL, DeVos M, Dubinsky 
M, Edwards C, Essers J, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges 
M, Gieger C, Glas J, Goyette P, Hakonarson H, Haritunians T, Hart A, Hawkey C, 
Hedl M, Hu X, Hui KY, Jostins L, Kugathasan S, Kupcinskas L, Latiano A, Laukens 
D, Lawrance IC, Lee JC, Lees CW, Louis E, Mahy G, Mansfield J, Mathew CG, 
McGovern DP, Morgan AR, Mowat C, Newman W, Ning K, Palmieri O, Parkes M, 
Potocnik U, Prescott NJ, Radford-Smit G, Raychaudhuri S, Regueiro M, Ripke S, 
Rotter JI, Russell RK, Sanderson JD, Satsangi J, Schadt EE, Schumm PL, Sharma Y, 
Simms LA, Spain SL, Sventoraityte J, Targan SR, Taylor KD, Theatre E, Tremelling 
M, Verspaget HW, Wei Z, Wilson DC, Xavier RJ, Zeissig S, Zhang B, Zhao H.

Author information:
(1)Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, 
Cambridge, UK.

Primary sclerosing cholangitis (PSC) is a severe liver disease of unknown 
etiology leading to fibrotic destruction of the bile ducts and ultimately to the 
need for liver transplantation. We compared 3,789 PSC cases of European ancestry 
to 25,079 population controls across 130,422 SNPs genotyped using the 
Immunochip. We identified 12 genome-wide significant associations outside the 
human leukocyte antigen (HLA) complex, 9 of which were new, increasing the 
number of known PSC risk loci to 16. Despite comorbidity with inflammatory bowel 
disease (IBD) in 72% of the cases, 6 of the 12 loci showed significantly 
stronger association with PSC than with IBD, suggesting overlapping yet distinct 
genetic architectures for these two diseases. We incorporated association 
statistics from 7 diseases clinically occurring with PSC in the analysis and 
found suggestive evidence for 33 additional pleiotropic PSC risk loci. Together 
with network analyses, these findings add to the genetic risk map of PSC and 
expand on the relationship between PSC and other immune-mediated diseases.

DOI: 10.1038/ng.2616
PMCID: PMC3667736
PMID: 23603763 [Indexed for MEDLINE]